NYC VC Fund Launch: Star51 Capital First Close of Medtech Venture Fund
New York-based Star51 Capital announced the first close of its inaugural medtech venture fund on June 11, 2026, anchored by Abbott and Mayo Clinic.
fund-close - VC Tracker Resources
Discover comprehensive resources and guides related to fund-close. Our comprehensive guides cover VC analysis preparation, investment resources, and practical advice for investors and analysts.
Whether you're an investor preparing for market analysis, a portfolio manager helping with investment tracking, or an analyst looking for resources, you'll find valuable insights in the articles below.
Related Articles (33 articles)
NYC VC Fund News: Dimension Capital Files for $750M Fund III at ML × Life Sciences Intersection
New York-based Dimension Capital filed SEC Form D in June 2026 seeking up to $750M for its third fund, following $350M Fund I and $500M Fund II.
NYC VC Fund Launch: Blue Cloud Ventures Closes Fund V, Crosses $1B AUM
New York-based Blue Cloud Ventures announced the final close of Fund V on June 2, 2026, bringing total AUM above $1 billion for enterprise SaaS and AI growth investing.
NYC VC Fund Launch: Opto Investments Closes AI-Focused Venture Fund for RIAs
New York-based Opto Investments announced the close of its AI-focused venture fund on May 28, 2026, providing RIA and family office clients exposure to foundational AI infrastructure.
July 2025 NYC VC Fund Roundup: Boldstart $250M, Betaworks $66M, and 49 Global Fund Closes
July 2025 brought Boldstart's $250M Fund VII, Betaworks' $66M AI fund, and Verified Capital's $175M debut — plus $6.77B in global new VC dry powder.
July 2025 Life Sciences Mega Close: Frazier Life Sciences Closes $1.3B Fund XII
Frazier Life Sciences closed Fund XII at over $1.3 billion on July 31, 2025 — one of the largest biotech venture funds closed in July 2025.